• Home
  • Search Results

Search Results

2518 studies match your search
Open

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Have you been histologically or cytologically confirmed to have Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma that is considered incurable by local therapies? If so, you may be able to participate in a research study seeking to find out if Amivantamab Monotherapy and/or Amivantamab in Addition to Standard of Care Therapeutic Agents can be an effective traetment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Not currently enrolling

Vaginal and Cervical Sample Study

In this study, we want to see if collecting vaginal samples on your own will give us the same results as when a doctor collects a cervical sample. We want to learn more about newer ways to test for cervical cancer.

Age & Gender
  • 25 years ~ 99 years
  • Female
Study Interest
  • Cancer (Cervical)
  • Women's Health
Open

Social Situations Study

Are you an adult between the ages of 18 and 35? Are you interested in brain research? If so, you may be able to participate in a study to see how people see social interactions in different situations. Compensation provided.

Age & Gender
  • 18 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Brain, Head, Nervous System
  • Opinions and Perceptions
Not currently enrolling

Eosinophilic Gastritis Study

We are trying to see whether Dupixent is a potential treatment for kids and adults with Eosinophilic Gastritis.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Stomach, Digestion and Gut Health
  • Rare Diseases
Not currently enrolling

Speech Production and Perception Study

My name is Halden Levin, and I am an undergraduate Linguistics major. For my honors thesis, I am investigating factors influencing speech production and perception in American English and Taiwanese Mandarin. Researching these factors will allow us to better understand speech production and perception.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Language and Speech
  • UNC Students (undergrad, grad, professional)
Visit Location
Open

Social Connections in Older Autistic and Neurotypical Adults Study

Are you a person aged 65 or older who has dealt with mental health issues before? We are looking for neurotypical adults like you to join our fully remote study! Individuals who do not leave the home often, or who do not have many social connections, are still invited to participate in this study. All degrees of social and community connection are welcome. Compensation provided.

Age & Gender
  • 55 years ~ 99 years
  • Male, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Infant cortisol and microbiome study

This study aims to understand how we can use fecal samples to measure cortisol levels in babies. Cortisol is used to measure stress biologically, and past research has used saliva or blood samples to do so. However, these measures can be hard to collect in infants, whereas diapers are relatively easy to obtain. We are aiming to determine whether cortisol in fecal samples changes throughout the day, like saliva or blood samples, or whether they are consistent like in urine. We will also use these data to investigate relationships between cortisol and composition of the gut microbiome, health, and infant distress. We are also measuring the composition of the skin microbiome to understand how the people a baby comes into contact with can affect their health.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
  • Mental and Emotional Health
  • Opinions and Perceptions
  • and 4 more
Open

A Phase III Multicenter Randomized Trial to Study HQP1351 in Patients with Chronic Myeloid Leukemia (CML)

Have you been diagnosed with Chronic Myeloid Leukemia, have a T315I mutation, and previously treated with at least two tyrosine kinase inhibitors (TKIs)? You might be able to participate in this study.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Not currently enrolling

Akero 105

We are studying an investigational drug, Efruxifermin, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with NASH (non-alcoholic steatohepatitis) and MASH (metabolic dysfunction-associated steatohepatitis).

Age & Gender
  • 18 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

This research study is being done in participants with advanced B-cell malignancies such as some types of lymphomas or leukemias. B-cell malignancies express a protein called the Bruton's tyrosine kinase (BTK), which has been shown to help the tumor cells grow and survive. The investigational drug, AC676, has been designed to recognize the BTK protein, and marks it for destruction. By destroying the BTK protein, the malignancy may be stopped from growing. "Investigational" means the study drug being tested is not approved by the FDA. This is an open-label study, meaning all patients who are eligible to participate will receive study drug. The key purposes of this study are to: ● Test the study drug at different dose levels (dose-escalation) and to determine the highest dose that can be taken without side effects that can't be tolerated (referred to as maximum tolerated dose or MTD). ● Determine what dose of

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research